About Us
Civil society organizations (CSOs) play a crucial role in immunization, and maternal, newborn and child health (MNCH). More than 4000 CSOs - including non-governmental organizations, advocacy organizations, professional and community associations, faith-based organizations and academia from around the world - come together to form the Gavi CSO Constituency. Together we help advance Gavi, the Vaccine Alliance vision of a world where all children are reached with life-saving vaccines.
The role of CSOs in immunization is multi-faceted and includes: direct service provision, creating demand for vaccination and child health services, advocating for increased access to immunization and acting as a watchdog to ensure that government and international actors are accountable to the people and communities they serve. CSOs have one seat on the Gavi Board and also participate in Board committees and task teams.
Find out more about Gavi, the Vaccine Alliance. 
Latest News

Dear friends of the Gavi CSO Constituency, 

as you might be aware, the Gavi Mid Term Review meeting has just started today, in Abu Dhabi, and will feature a great range of diverse discussions around progress and challenges the Gavi Alliance have faced so far. 

The Mid-Term Review is an important moment to reflect on Gavi’s successes, as well as challenges and opportunities in 2018 onwards. Based on these reflections, it is an opportune moment for all Alliance Partners to adjust their strategies and programmes for the remainder of Gavi’s current strategy, and to Gavi 5.0, to drive more equitable coverage. We encourage the Gavi Board members, donors, countries and all the Alliance partners to take into account the following areas of concern:

● Coverage and Equity: Most efforts in the past decade have focused on supply side, however vaccine shortages in the poorest countries are putting lives at risk. Further, there has been limited investment in community engagement and demand creation.

● Transition and Co-Financing: Gross National Income (GNI) is not an adequate indicator of a country’s readiness to transition nor the functionality of its essential immunization system. It is unacceptable for countries to transition when they have low or falling immunization rates.

● Market Shaping: Without health markets vaccines are not available and that leaves children vulnerable. Concerningly a number of key WHO recommended vaccines have very few suppliers, especially for PCV, rotavirus, HPV, IPV and Yellow Fever vaccines.

Value for Money for Countries and People: The ultimate beneficiaries of Gavi support are infants, children, caregivers, families and communities and this should be reflected in Gavi policy and funding approaches.

We call on a response and action to the above areas of concern to ensure Alliance support continues to transform immunisation and health systems for the benefit of the world’s children. 

We are pleased to be able to share the Gavi CSO Statement on the Gavi MTR here (in French and English). 

Sincerely yours,

Your Steering Committee